Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Sunlight is an important determinant of vitamin D serum concentrations in cystic fibrosis

Abstract

Background/Objectives:

The increase of bone disease in adult cystic fibrosis (CF) patients is partly attributed to inadequate serum concentrations of 25-OH cholecalciferol (25 (OH) D) blamed on fat malabsorption. Based on physiological, clinical and biochemical observations this pathogenesis is debatable. The objective was to ascertain the relative importance of different 25 (OH) D sources.

Subjects/Methods:

Over 4 consecutive years, 474 annual 25 (OH) D serum concentrations from 141 CF patients of all ages were compared with values of healthy peers and weighed against annual ultraviolet B (UVB) exposure.

Results:

Ranked per month, 25 (OH) D concentrations depicted a curve strikingly parallel to the amount of UVB exposure in the preceding months. A significant difference exists between 25 (OH) D concentrations in the ‘Months with high UVB exposure’ (May–October) and the ‘Months with low UVB exposure’ (November–April) but not with healthy controls in the same period.

Conclusions:

25 (OH) D concentrations clearly respond to the amount of sunshine in preceding months. They are not clearly influenced by daily oral supplements of 800 IU of cholecalciferol. Sun exposure should be encouraged, and the recommended dosage of oral supplements increased.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Andersen R, Molgaard C, Skovgaard LT, Cashman KD, Chabros E, Charzewska J et al. (2005). Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 59, 533–541.

    Article  CAS  Google Scholar 

  • Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL et al. (2005). Consensus statement: guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 90, 1888–1896.

    Article  CAS  Google Scholar 

  • Borowitz D, Baker RD, Stallings V, Consensus Committee (2002). Consensus report on nutrition for pediatric patients with cystic fibrosis. JPGN 35, 246–259.

    PubMed  Google Scholar 

  • Borowitz D, Baker SS, Duffy L, Baker RD, Fitzpatrick L, Gyamfi J et al. (2004). Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 145, 322–326.

    Article  CAS  Google Scholar 

  • Boyle MP, Noschese ML, Watts SL, Davis ME, Stenner SE, Lechtzin N (2005). Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med 172, 212–217.

    Article  Google Scholar 

  • Buntain HM, Greer RM, Schluter PJ, Wong JC, Batch JA, Potter JM et al. (2004). Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 59, 149–155.

    Article  CAS  Google Scholar 

  • Carr SB, Dinwiddie R (1996). Annual review or continuous assessment? J R Soc Med 89, 3–7.

    Article  Google Scholar 

  • Cashman KD (2007). Vitamin D in childhood and adolescence. Postgrad Med J 83, 230–235.

    Article  CAS  Google Scholar 

  • Chandra P, Wolfenden LL, Ziegler TR, Tian J, Luo M, Stecenko A et al. (2007). Treatment of vitamin D deficiency with UV light in patients with malabsorption syndromes: a case series. Photodermatol Photoimmunol Photomed 23, 179–185.

    Article  CAS  Google Scholar 

  • Chavasse RJ, Francis J, Balfour-Lynn I, Rosenthal M, Bush A (2004). Serum vitamin D levels in children with cystic fibrosis. Pediatr Pulmonol 38, 119–122.

    Article  CAS  Google Scholar 

  • Cystic fibrosis foundation (2006). Cystic Fibrosis Foundation, Patient Registry 2005. Cystic fibrosis foundation: Bethesda, MD.

  • Donovan DS, Papadopoulos A, Staron RB, Addesso V, Schulman L, McGregor C et al. (1998). Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 158, 1892–1899.

    Article  Google Scholar 

  • Green D, Carson K, Leonard A, Davis JE, Rosenstein B, Zeitlin P et al. (2008). Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. J Pediatr 153, 554–559.

    Article  CAS  Google Scholar 

  • Green D, Leonard A, Paranjape SM, Rosenstein BJ, Zeitlin PL, Mogayzel PL (2010). Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients. J Cyst Fibros 9, 143–149.

    Article  CAS  Google Scholar 

  • Gronowitz E, Larko O, Gilljam M, Hollsing A, Lindblad A, Mellstrom D et al (2005). Ultraviolet B radiation improves serum levels of vitamin D in patients with cystic fibrosis. Acta Paediatr 94, 547–552.

    Article  Google Scholar 

  • Gronowitz E, Mellstrom D, Strandvik B (2004). Normal annual increase of bone mineral density during two years in patients with cystic fibrosis. Pediatrics 114, 435–442.

    Article  Google Scholar 

  • Guillemant J, Le HT, Maria A, Allemandou A, Guillemant S (2001). Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements. Osteoporos Int 12, 875–879.

    Article  CAS  Google Scholar 

  • Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003). Human serum 25-hydroxcholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77, 204–210.

    Article  CAS  Google Scholar 

  • Holick MF (1996). Vitamin D in health and prevention of metabolic disease. In: Rosen C. Totowa (ed). Osteoporosis: Diagnostic and Therapeutic Principles. Humana Press: NJ, pp 29–43.

    Chapter  Google Scholar 

  • Holick MF (1999). Biologic effects of light: historical and new perspectives. In: Holick MF and Jung EG (eds). Biologic Effects of Light. Kluwer Academic Publishers: Boston, pp 11–32.

    Google Scholar 

  • Khazai NB, Judd SE, Jeng L, Wolfenden LL, Stecenko A, Ziegler TR et al. (2009). Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol and UV light. J Clin Endocrinol Metab 94, 2037–2043.

    Article  CAS  Google Scholar 

  • Lark RK, Lester GE, Ontjens DA, Blackwood AD, Hollis BW, Hensler MM et al. (2001). Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 73, 602–606.

    Article  CAS  Google Scholar 

  • Malabanan A, Veronikis IE, Holick MF (1998). Redefining vitamin D insufficiency. Lancet 351, 805–806.

    Article  CAS  Google Scholar 

  • Mortensen LA, Chan GM, Alder SC, Marshall BC (2000). Bone mineral status in prepubertal children with cystic fibrosis. J Pediatr 136, 648–652.

    Article  CAS  Google Scholar 

  • Need AG, Morris HA, Horowitz M, Christopher Nordin BE (1993). Effects of skin thickness, age, body fat and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr 58, 882–885.

    Article  CAS  Google Scholar 

  • Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V (2002). Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab 87, 2024–2032.

    Article  CAS  Google Scholar 

  • Rovner AJ, Stallings VA, Schall JI, Leonard MB, Zemel BS (2007). Vitamin D insufficiency in children, adolescents and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 86, 1694–1699.

    Article  CAS  Google Scholar 

  • Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG et al. (2002). Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 1, 51–75.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors’ contributions are as follows: ER, SV participated in all stages of the research project. ER, CW and SV conceived the study and the collection of data. JMK and JDS provided data on control patients. ER, CW and SV carried out the data analysis, and ER and SV wrote the manuscript. All authors read and approved the final manuscript. We would like to thank Nele Iserentant and Santiago Grau for linguistic help in the drawing of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Robberecht.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robberecht, E., Vandewalle, S., Wehlou, C. et al. Sunlight is an important determinant of vitamin D serum concentrations in cystic fibrosis. Eur J Clin Nutr 65, 574–579 (2011). https://doi.org/10.1038/ejcn.2010.280

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2010.280

Keywords

This article is cited by

Search

Quick links